<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4723">
  <stage>Registered</stage>
  <submitdate>30/07/2014</submitdate>
  <approvaldate>30/07/2014</approvaldate>
  <nctid>NCT02305290</nctid>
  <trial_identification>
    <studytitle>Upper GI Outcomes Following EMR</studytitle>
    <scientifictitle>Outcomes of Endoscopic Resection in the Upper Gastrointestinal Tract</scientifictitle>
    <utrn />
    <trialacronym>UGI-EMR</trialacronym>
    <secondaryid>HREC2014/7/4.6 (4031)</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Adenoma, Villous</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Bowel - Back passage (rectum) or large bowel (colon)</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Other endocrine disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Endoscopic Mucosal Resection

Endoscopic Mucosal Resection - Patients who are referred for Endoscopic Mucosal Resection of Upper Gastrointestinal Lesions will be included in this cohort.


Treatment: surgery: Endoscopic Mucosal Resection


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Observed procedural data - Number of Participants with Adverse Events as a Measure of Safety and Tolerability Outcomes</outcome>
      <timepoint>14 days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Analysis of the costs of this procedure compared to previous treatments - Perform cost-utility analyses comparing different treatment approaches for UGIT lesions</outcome>
      <timepoint>14 days</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  UGIT lesion &gt; 10mm

          -  Lesion limited to the mucosal and/or submucosal layer (T1 lesion)

          -  Aged 18 years or older</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Lesion less than 10mm

          -  Gastric lesion involves the muscularis propria (T2 lesion) on other staging modalities
             such as endoscopic ultrasonography (EUS)

          -  Aged younger than 18 years</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2019</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
    <hospital>Westmead Endoscopy Unit - Westmead</hospital>
    <postcode>2145 - Westmead</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Professor Michael Bourke</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to evaluate the long-term outcomes of Endoscopic Resection (ER)
      of superficial lesions of the Upper Gastrointestinal Tract(UGIT)</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02305290</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael J Bourke, MBBS</name>
      <address>Western Sydney Local Health District</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Rebecca Sonson, BN</name>
      <address />
      <phone>98455555</phone>
      <fax />
      <email>Rebecca.Sonson@health.nsw.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>